Lannett reported $-23942000 in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Amerisourcebergen ABC:US $ 658.72M 196M
Aurora Cannabis Inc ACB:CN C$ -86814000 23.72M
Canopy Growth Corp WEED:CN -114437000 194.91M
Cardinal Health CAH:US 374M 93M
Corcept Therapeutics CORT:US $ 31.43M 4.66M
Depomed DEPO:US $ 12.09M 1.51M
JAZZ PHA JAZZ:US 126.35M 38.8M
Knight Therapeutics Inc GUD:CN C$ 2.34M 2.65M
Lannett LCI:US $ -23942000 3.64M
Mckesson MCK:US $ 1074M 340M
Nektar Therapeutics NKTR:US $ -47713000 67.37M
Novartis NVS:US 3.32B 176M
Omeros OMER:US $ -37438000 2.39M
Pacira Pharmaceuticals PCRX:US $ 13.18M 8.55M
Perrigo Ordinary Shares PRGO:US $ 2.6M 20.5M
Pfizer PFE:US $ 12099M 2104M
Prestige Brands PBH:US $ 87.01M 9.59M
Supernus Pharmaceuticals SUPN:US $ 11.35M 9.38M
Teva Pharmaceutical TEVA:IT 734M 55M
Zoetis ZTS:US $ 737M 57M